863 studies found for:    Open Studies | "Carcinoma, Bronchogenic"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Carcinoma, Bronchogenic"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Efficacy and Safety Study of Gefitinib in Squamous NSCLC Patients Who Failed First-Line Chemotherapy
Condition: Squamous Cell Carcinoma of Bronchus
Intervention: Drug: Gefitinib
2 Unknown  Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: Bendamustin/Ribomustin
3 Recruiting Phase I Trial of Afatinib (BIBW 2992) and Dasatinib in Non-small Cell Lung Cancer (NSCLC)
Conditions: Lung Cancer;   Non-small Cell Lung Cancer (NSCLC)
Interventions: Drug: Dasatinib - 1A;   Drug: Afatinib - 1A;   Drug: Dasatinib - 1B;   Drug: Afatinib - 1B
4 Not yet recruiting Chemotherapy Combined With Yangzhengxiaoji Capsule in Patients With Advanced Non-Small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Interventions: Drug: Yangzhengxiaoji Capsule;   Drug: Placebo Capsule
5 Recruiting SC16LD6.5 in Recurrent Small Cell Lung Cancer
Condition: Recurrent Small Cell Lung Cancer
Intervention: Drug: SC16LD6.5
6 Unknown  Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
Condition: Non-Small Cell Lung Cancer
7 Recruiting Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers
Conditions: Lung Cancer;   Non-small-cell Lung Carcinoma
Intervention: Device: CT-simulation and 4D PET-CT
8 Unknown  Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: malate Given orally
9 Recruiting Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Condition: Lung Cancer
Interventions: Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Drug: cisplatin;   Drug: etoposide
10 Unknown  Oral Green Tea Extract for Small Cell Lung Cancer
Condition: Small Cell Lung Carcinoma
Intervention: Dietary Supplement: epigallocatechin gallate
11 Recruiting PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy
Conditions: Melanoma;   Renal Cell Carcinoma (RCC);   Non-small Cell Lung Cancer (NSCLC)
Intervention: Radiation: PET/CT imaging with [18F] 2-deoxy-2-(18F)fluoro-D-glucose (FDG)
12 Unknown  Detection of Chromosomal Aberrations in Non-small Cell Lung Cancer (NSCLC) Using Fluorescent in Situ Hybridization (FISH) (ALK Test)
Condition: Non-small Cell Lung Cancer (NSCLC)
13 Recruiting Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer
Condition: Small Cell Lung Cancer
Intervention: Biological: HLA-A*2402-restricted CDCA1 and KIF20A peptides
14 Recruiting Pilot Study to Determine Biodistribution of MM-398 and Feasibility of Ferumoxytol as a Tumor Imaging Agent
Conditions: Solid Tumors;   Triple Negative Breast Cancer;   Non Small Cell Lung Cancer;   Colorectal Cancer;   ER/PR Positive Breast Cancer;   Pancreatic Cancer;   Ovarian Cancer;   Gastric Cancer;   Gastro-Esophageal Junction Adenocarcinoma;   Head and Neck Cancer
Intervention: Drug: Ferumoxytol followed by MM-398
15 Recruiting ADAM-Afatinib Diarrhea Assessment and Management
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: afatinib;   Drug: loperamide
16 Recruiting Minimally Invasive or Open Surgery for Lung Cancer: Pain, Quality of Life and Economy.
Condition: Nonsmall Cell Lung Cancer Cellular Diagnosis
Interventions: Procedure: Anterolateral thoracotomy;   Procedure: Posterolateral thoracotomy;   Procedure: VATS;   Procedure: Anterolateral Thoracotomy
17 Recruiting A Phase I/II Study of Nab-Paclitaxel, or Paclitaxel, Plus Carboplatin With Concurrent Radiation Therapy Followed by Consolidation in Patients With Favorable Prognosis Inoperable Stage IIIA/B NSCLC
Interventions: Drug: NAB-PACLITAXEL;   Drug: PACLITAXEL
18 Recruiting Cetuximab, Cisplatin, Docetaxel, Radiation Therapy, and Surgery in Treating Patients With Stage IIIB Non-Small Cell Lung Cancer That Can Be Removed by Surgery
Condition: Lung Cancer
Interventions: Drug: cetuximab;   Drug: cisplatin;   Drug: docetaxel;   Radiation: Radiotherapy;   Procedure: therapeutic conventional surgery
19 Not yet recruiting Study of the Telomerase Vaccine GV1001 to Treat Patients With Inoperable Stage III Non-small Cell Lung Cancer
Condition: Inoperable Stage III Non-small Cell Lung Cancer
Interventions: Drug: GV1001;   Drug: normal saline
20 Recruiting A Study of Necitumumab in the First-Line Treatment of Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC)
Condition: Squamous Non-small Cell Lung Cancer
Interventions: Drug: Necitumumab;   Drug: Gemcitabine;   Drug: Cisplatin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years